Cultivation of kidney mesangial cells (MC) is easily established and widely used. MCs produce several complementary regulatory proteins (C). We studied whether MC synthesized components C (C3, C5, C8). MC culture was established from the normal portion of nephrectomy for kidney cancer. After growing to a close meeting in RPMI / 17% FBS and resting 24 hours in RPMI / 0.5% FBS, MC stimulated up to 72 hours with IL-1β or IL-6 (10, 100, 1000 U / mL).
Both C5 and C8 detection by ELISA. While C3 is present in supernatant in basal conditions (15.5-107.6 ng / 10 (6) cells / 24 hours) in different MC lines. IL-1β regulates synthesis with 2.4-4.5 folds, while IL-6 does not show any effect. The c3 synthetic rate is cell 1.76 ng / 10 (6) under IL-1 stimulation versus basal level 0.37 ng / hour / 10 (6) cells. MC C3 production, especially induced by IL-1 may have pathogenetic relevance in glomerulonephritis.
Rooperol, cytokine synthesis inhibitors, reduces breathing explosions on leukocytes and human macrophies and mice.
Chemiluminescence enhanced by Luminol is measured in all fresh human blood, or human neutrophils are isolated from the blood of heparation, macrophages of alveolar humans and macrophages of alveolar rats which are stimulated with endotoxin bacteria (LPS). Esther TetraAceTate from Rooperol, a recatechol that shows anticoytokine activity, added to the cell simultaneously with LPS inhibiting the breathing explosion. The effective concentration of Rooperol is in the range of 1-10 mothers depending on the type of cell and in accordance with the inhibition of the production of nitrate oxide by macrophages of mice alveolar. Thus Roerol can reduce some effects of excessive phagocytic activity and inflammatory reactions but by extinguishing free radical production can also reduce resistance to bacterial infections.
Leptin increases survival and induces migration, degranulation, and synthesis of cytokines from human basophyl.
Basophils are the rarest leukocytes in human blood, but are now recognized as one of the most important immunomodulatory cells and the effector in allergic inflammation. Leptin, a member of the Cytokine IL-6 family, has a metabolic effect as an adipocine, and is also known to participate in the pathogenesis of inflammatory reactions. Because there is an epidemiological relationship between obesity and allergies, we examine whether the basophyl function is modified by leptin.
We found that the human basophyl expressed Leptin receptor (LEPR) at MRNA and surface protein levels, which was regulated by IL-33. Leptin exerts strong effects on several basophyl functions. This causes a strong migration response to human basophyl, potentially similar to the basophil-active kemokine. Also, Leptin increases the survival of human basophyl, even though its potential is less than IL-3. In addition, CD63, the marker of basophil activation is stated on the cell surface, regulated by leptin, the effect is neutralized by blocking LEPR.
Basophyl degranulation assessment and cytokine synthesis found that leptin shows a strong priming effect on human basophyl degranulation in response to FCεRI aggregation and induces Th2, but not the production of cytokines by cells. In short, these findings indicate that leptin may be the main molecule that mediates the effects of adipocytes in inflammatory cells such as basophiles by binding LEPR and activating cellular functions, which may worsen allergic inflammation.
Learn at the synthesis of complement components by human kidney mesangial cells in culture. Assessment of cytokine effects.
Cultivation of kidney mesangial cells (MC) is easily established and widely used. MCs produce several complementary regulatory proteins (C). We studied whether MC synthesized components C (C3, C5, C8). MC culture was established from the normal portion of nephrectomy for kidney cancer. After growing to a close meeting in RPMI / 17% FBS and resting 24 hours in RPMI / 0.5% FBS, MC stimulated up to 72 hours with IL-1β or IL-6 (10, 100, 1000 U / mL). Both C5 and C8 detection by ELISA.
While C3 is present in supernatant in basal conditions (15.5-107.6 ng / 10 (6) cells / 24 hours) in different MC lines. IL-1β regulates synthesis with 2.4-4.5 folds, while IL-6 does not show any effect. The c3 synthetic rate is cell 1.76 ng / 10 (6) under IL-1 stimulation versus basal level 0.37 ng / hour / 10 (6) cells. MC C3 production, especially induced by IL-1 may have pathogenetic relevance in glomerulonephritis.
Rooperol, cytokine synthesis inhibitors, reduces breathing explosions on leukocytes and human macrophies and mice.
Chemiluminescence enhanced by Luminol is measured in all fresh human blood, or human neutrophils are isolated from the blood of heparation, macrophages of alveolar humans and macrophages of alveolar rats which are stimulated with endotoxin bacteria (LPS). Esther TetraAceTate from Rooperol, a recatechol that shows anticoytokine activity, added to the cell simultaneously with LPS inhibiting the breathing explosion. The effective concentration of Rooperol is in the range of 1-10 mothers depending on the type of cell and in accordance with the inhibition of the production of nitrate oxide by macrophages of mice alveolar. Thus Roerol can reduce some effects of excessive phagocytic activity and inflammatory reactions but by extinguishing free radical production can also reduce resistance to bacterial infections.

Leptin increases survival and induces migration, degranulation, and synthesis of cytokines from human basophyl.
Basophils are the rarest leukocytes in human blood, but are now recognized as one of the most important immunomodulatory cells and the effector in allergic inflammation. Leptin, a member of the Cytokine IL-6 family, has a metabolic effect as an adipocine, and is also known to participate in the pathogenesis of inflammatory reactions. Because there is an epidemiological relationship between obesity and allergies, we examine whether the basophyl function is modified by leptin. We found that the human basophyl expressed Leptin receptor (LEPR) at MRNA and surface protein levels, which was regulated by IL-33.
Leptin exerts strong effects on several basophyl functions. This causes a strong migration response to human basophyl, potentially similar to the basophil-active kemokine. Also, Leptin increases the survival of human basophyl, even though its potential is less than IL-3. In addition, CD63, the marker of basophil activation is stated on the cell surface, regulated by leptin, the effect is neutralized by blocking LEPR. Basophyl degranulation assessment and cytokine synthesis found that leptin shows a strong priming effect on human basophyl degranulation in response to FCεRI aggregation and induces Th2, but not the production of cytokines by cells.
Recombinant Human AITRL (AITRL Human) |
|
MBS555501-0005mg |
MyBiosource |
0.005mg |
EUR 220 |
Recombinant Human AITRL (AITRL Human) |
|
MBS555501-002mg |
MyBiosource |
0.02mg |
EUR 320 |
Recombinant Human AITRL (AITRL Human) |
|
MBS555501-5x002mg |
MyBiosource |
5x0.02mg |
EUR 1300 |
TWEAK, recombinant / TNFSF12, recombinant (Human) |
|
054-85 |
PHOENIX PEPTIDE |
10 μg |
EUR 261.36 |
Recombinant Human PGⅡ |
|
E21-RA29-1 |
EnoGene |
- |
Ask for price |
recombinant human EJ |
|
E4A10X34 |
EnoGene |
100ug |
EUR 595 |
recombinant human KS |
|
E4A10X35 |
EnoGene |
100ug |
EUR 595 |
recombinant human Ha |
|
E4A10X36 |
EnoGene |
100ug |
EUR 595 |
recombinant human Ku |
|
E4A10X39 |
EnoGene |
100ug |
EUR 595 |
Recombinant Human GH |
|
MBS7608417-005mg |
MyBiosource |
0.05mg |
EUR 405 |
Recombinant Human GH |
|
MBS7608417-02mg |
MyBiosource |
0.2mg |
EUR 760 |
Recombinant Human GH |
|
MBS7608417-1mg |
MyBiosource |
1mg |
EUR 2175 |
Recombinant Human GH |
|
MBS7608417-5x1mg |
MyBiosource |
5x1mg |
EUR 8410 |
Recombinant Human GS |
|
MBS7608504-005mg |
MyBiosource |
0.05mg |
EUR 345 |
Recombinant Human GS |
|
MBS7608504-02mg |
MyBiosource |
0.2mg |
EUR 635 |
Recombinant Human GS |
|
MBS7608504-1mg |
MyBiosource |
1mg |
EUR 1800 |
Recombinant Human GS |
|
MBS7608504-5x1mg |
MyBiosource |
5x1mg |
EUR 6955 |
Recombinant Human C6 |
|
MBS7608602-005mg |
MyBiosource |
0.05mg |
EUR 345 |
Recombinant Human C6 |
|
MBS7608602-02mg |
MyBiosource |
0.2mg |
EUR 635 |
Recombinant Human C6 |
|
MBS7608602-1mg |
MyBiosource |
1mg |
EUR 1800 |
Recombinant Human C6 |
|
MBS7608602-5x1mg |
MyBiosource |
5x1mg |
EUR 6955 |
Recombinant Human C5 |
|
MBS7609068-005mg |
MyBiosource |
0.05mg |
EUR 345 |
Recombinant Human C5 |
|
MBS7609068-02mg |
MyBiosource |
0.2mg |
EUR 635 |
Recombinant Human C5 |
|
MBS7609068-1mg |
MyBiosource |
1mg |
EUR 1800 |
Recombinant Human C5 |
|
MBS7609068-5x1mg |
MyBiosource |
5x1mg |
EUR 6955 |
Recombinant Human Rb |
|
MBS7609212-005mg |
MyBiosource |
0.05mg |
EUR 470 |
Recombinant Human Rb |
|
MBS7609212-02mg |
MyBiosource |
0.2mg |
EUR 885 |
Recombinant Human Rb |
|
MBS7609212-1mg |
MyBiosource |
1mg |
EUR 2540 |
Recombinant Human Rb |
|
MBS7609212-5x1mg |
MyBiosource |
5x1mg |
EUR 9820 |
Recombinant Human FH |
|
MBS7609262-005mg |
MyBiosource |
0.05mg |
EUR 560 |
Recombinant Human FH |
|
MBS7609262-02mg |
MyBiosource |
0.2mg |
EUR 1060 |
Recombinant Human FH |
|
MBS7609262-1mg |
MyBiosource |
1mg |
EUR 3065 |
Recombinant Human FH |
|
MBS7609262-5x1mg |
MyBiosource |
5x1mg |
EUR 11850 |
Recombinant Human C4 |
|
MBS7609327-005mg |
MyBiosource |
0.05mg |
EUR 405 |
Recombinant Human C4 |
|
MBS7609327-02mg |
MyBiosource |
0.2mg |
EUR 760 |
Recombinant Human C4 |
|
MBS7609327-1mg |
MyBiosource |
1mg |
EUR 2175 |
Recombinant Human C4 |
|
MBS7609327-5x1mg |
MyBiosource |
5x1mg |
EUR 8410 |
Recombinant Human C4 |
|
MBS7609328-005mg |
MyBiosource |
0.05mg |
EUR 405 |
Recombinant Human C4 |
|
MBS7609328-02mg |
MyBiosource |
0.2mg |
EUR 760 |
Recombinant Human C4 |
|
MBS7609328-1mg |
MyBiosource |
1mg |
EUR 2175 |
Recombinant Human C4 |
|
MBS7609328-5x1mg |
MyBiosource |
5x1mg |
EUR 8410 |
Recombinant Human GC |
|
MBS7616369-005mg |
MyBiosource |
0.05mg |
EUR 405 |
Recombinant Human GC |
|
MBS7616369-02mg |
MyBiosource |
0.2mg |
EUR 760 |
Recombinant Human GC |
|
MBS7616369-1mg |
MyBiosource |
1mg |
EUR 2175 |
Recombinant Human GC |
|
MBS7616369-5x1mg |
MyBiosource |
5x1mg |
EUR 8410 |
Recombinant Human HP |
|
MBS7614251-005mg |
MyBiosource |
0.05mg |
EUR 405 |
Recombinant Human HP |
|
MBS7614251-02mg |
MyBiosource |
0.2mg |
EUR 760 |
Recombinant Human HP |
|
MBS7614251-1mg |
MyBiosource |
1mg |
EUR 2175 |
Recombinant Human HP |
|
MBS7614251-5x1mg |
MyBiosource |
5x1mg |
EUR 8410 |
Recombinant Human FH |
|
MBS7613325-005mg |
MyBiosource |
0.05mg |
EUR 405 |
Recombinant Human FH |
|
MBS7613325-02mg |
MyBiosource |
0.2mg |
EUR 760 |
Recombinant Human FH |
|
MBS7613325-1mg |
MyBiosource |
1mg |
EUR 2175 |
Recombinant Human FH |
|
MBS7613325-5x1mg |
MyBiosource |
5x1mg |
EUR 8410 |
Recombinant Human CP |
|
MBS7613562-005mg |
MyBiosource |
0.05mg |
EUR 405 |
Recombinant Human CP |
|
MBS7613562-02mg |
MyBiosource |
0.2mg |
EUR 760 |
Recombinant Human CP |
|
MBS7613562-1mg |
MyBiosource |
1mg |
EUR 2175 |
Recombinant Human CP |
|
MBS7613562-5x1mg |
MyBiosource |
5x1mg |
EUR 8410 |
Recombinant Human TH |
|
MBS7613924-005mg |
MyBiosource |
0.05mg |
EUR 345 |
Recombinant Human TH |
|
MBS7613924-02mg |
MyBiosource |
0.2mg |
EUR 635 |
Recombinant Human TH |
|
MBS7613924-1mg |
MyBiosource |
1mg |
EUR 1800 |
Recombinant Human TH |
|
MBS7613924-5x1mg |
MyBiosource |
5x1mg |
EUR 6955 |
Recombinant Human AR |
|
MBS7612815-005mg |
MyBiosource |
0.05mg |
EUR 405 |
Recombinant Human AR |
|
MBS7612815-02mg |
MyBiosource |
0.2mg |
EUR 760 |
Recombinant Human AR |
|
MBS7612815-1mg |
MyBiosource |
1mg |
EUR 2175 |
Recombinant Human AR |
|
MBS7612815-5x1mg |
MyBiosource |
5x1mg |
EUR 8410 |
Recombinant Human GH |
|
P1223-.1 |
ApexBio |
10X10ug |
EUR 240 |
|
Description: Peptides & Proteins|Recombinant Proteins |
Recombinant Human GH |
|
P1223-.5 |
ApexBio |
50X10ug |
EUR 538.4 |
|
Description: Peptides & Proteins|Recombinant Proteins |
Recombinant human C5 |
|
A10C52 |
BioNC |
1 Each |
Ask for price |
Recombinant human TG |
|
A10K22 |
BioNC |
1 Each |
Ask for price |
Recombinant human EJ |
|
A10X34 |
BioNC |
1 Each |
Ask for price |
Recombinant human KS |
|
A10X35 |
BioNC |
1 Each |
Ask for price |
Recombinant human Ha |
|
A10X36 |
BioNC |
1 Each |
Ask for price |
Recombinant human Ku |
|
A10X39 |
BioNC |
1 Each |
Ask for price |
Recombinant human OJ |
|
A10X72 |
BioNC |
1 Each |
Ask for price |
DR3 (human):Fc (human), (recombinant) |
|
MBS566215-005mg |
MyBiosource |
0.05mg |
EUR 585 |
DR3 (human):Fc (human), (recombinant) |
|
MBS566215-5x005mg |
MyBiosource |
5x0.05mg |
EUR 2585 |
Recombinant Human REC8 |
|
MBS7613173-005mg |
MyBiosource |
0.05mg |
EUR 405 |
Recombinant Human REC8 |
|
MBS7613173-02mg |
MyBiosource |
0.2mg |
EUR 760 |
Recombinant Human REC8 |
|
MBS7613173-1mg |
MyBiosource |
1mg |
EUR 2175 |
Recombinant Human REC8 |
|
MBS7613173-5x1mg |
MyBiosource |
5x1mg |
EUR 8410 |
Recombinant Human PRL |
|
AP76222 |
SAB |
1mg |
EUR 2369 |
|
|
Recombinant Human NSE |
|
HEENP-1402 |
Cyagen |
5ug |
Ask for price |
Recombinant Human PDI |
|
HEENP-1601 |
Cyagen |
100ug |
Ask for price |
Recombinant Human EGF |
|
HEGFP-0501 |
Cyagen |
100ug |
Ask for price |
Recombinant Human BNP |
|
HEOPP-0211 |
Cyagen |
100ug |
Ask for price |
Recombinant Human C5a |
|
HEOPP-0306 |
Cyagen |
5ug |
Ask for price |
Recombinant Human EPG |
|
HEOPP-0503 |
Cyagen |
5ug |
Ask for price |
Recombinant Human LIF |
|
HEOPP-1202 |
Cyagen |
5ug |
Ask for price |
Recombinant Human MIA |
|
HEOPP-1301 |
Cyagen |
5ug |
Ask for price |
Recombinant Human MIF |
|
HEOPP-1308 |
Cyagen |
10ug |
Ask for price |
Recombinant Human NOV |
|
HEOPP-1407 |
Cyagen |
5ug |
Ask for price |
Recombinant Human OSM |
|
HEOPP-1503 |
Cyagen |
10ug |
Ask for price |
Recombinant Human OPG |
|
HEOPP-1506 |
Cyagen |
10ug |
Ask for price |
Recombinant Human PTN |
|
HEOPP-1607 |
Cyagen |
5ug |
Ask for price |
Recombinant Human SCF |
|
HEOPP-1902 |
Cyagen |
10ug |
Ask for price |
Recombinant Human SHH |
|
HEOPP-1907 |
Cyagen |
5ug |
Ask for price |
recombinant human CD4 |
|
E4A10C47 |
EnoGene |
100ug |
EUR 595 |
recombinant human BNP |
|
E4A10G08 |
EnoGene |
100ug |
EUR 595 |
recombinant human PF4 |
|
E4A10G10 |
EnoGene |
100ug |
EUR 595 |
recombinant human vWF |
|
E4A10G19 |
EnoGene |
100ug |
EUR 595 |
recombinant human OPN |
|
E4A10H21 |
EnoGene |
100ug |
EUR 595 |
recombinant human Tau |
|
E4A10L09 |
EnoGene |
100ug |
EUR 595 |
recombinant human MPO |
|
E4A10X01 |
EnoGene |
100ug |
EUR 595 |
recombinant human U1A |
|
E4A10X07 |
EnoGene |
100ug |
EUR 595 |
recombinant human GBM |
|
E4A10X14 |
EnoGene |
100ug |
EUR 595 |
Recombinant Human EGF |
|
EPT004 |
ELK Biotech |
10ug |
EUR 19.5 |
|
|
|
Description: Recombinant Human Epidermal Growth Factor is produced by our E.coli expression system and the target gene encoding Asn971-Arg1023 is expressed. |
Recombinant Human PTH |
|
EPT146 |
ELK Biotech |
50ug |
EUR 294.5 |
|
|
|
Description: Recombinant Human Parathyroid Hormone is produced by our E.coli expression system and the target gene encoding Ser32-Gln115 is expressed. |
Recombinant Human LIF |
|
EPT153 |
ELK Biotech |
10ug |
EUR 99.5 |
|
|
|
Description: Recombinant Human Leukemia Inhibitory Factor is produced by our E.coli expression system and the target gene encoding Ser23-Phe202 is expressed. |
Recombinant Human C3a |
|
EPT178 |
ELK Biotech |
50ug |
EUR 294.5 |
|
|
|
Description: Recombinant Human Complement Component C3a is produced by our E.coli expression system and the target gene encoding Ser672-Arg748 is expressed. |
Recombinant Human SCF |
|
EPT201 |
ELK Biotech |
50ug |
EUR 174.5 |
|
|
|
Description: Recombinant Human Stem Cell Factor is produced by our E.coli expression system and the target gene encoding Glu26-Ala189 is expressed. |
Recombinant Human p53 |
|
MBS143809-0002mg |
MyBiosource |
0.002mg |
EUR 360 |
Recombinant Human p53 |
|
MBS143809-0005mg |
MyBiosource |
0.005mg |
EUR 465 |
Recombinant Human p53 |
|
MBS143809-001mg |
MyBiosource |
0.01mg |
EUR 720 |
Recombinant Human p53 |
|
MBS143809-5x001mg |
MyBiosource |
5x0.01mg |
EUR 2905 |
Recombinant Human EGF |
|
MBS4159643-1mg |
MyBiosource |
1mg |
EUR 355 |
Recombinant Human EGF |
|
MBS4159643-5x1mg |
MyBiosource |
5x1mg |
EUR 1345 |
Recombinant Human GH1 |
|
MBS4159656-05mg |
MyBiosource |
0.5mg |
EUR 230 |
Recombinant Human GH1 |
|
MBS4159656-1mg |
MyBiosource |
1(mg) |
EUR 295 |
Recombinant Human GH1 |
|
MBS4159656-5x1mg |
MyBiosource |
5x1mg |
EUR 1090 |
Recombinant Human IL2 |
|
MBS4159676-005mg |
MyBiosource |
0.05mg |
EUR 230 |
Recombinant Human IL2 |
|
MBS4159676-01mg |
MyBiosource |
0.1mg |
EUR 290 |
Recombinant Human IL2 |
|
MBS4159676-1mg |
MyBiosource |
1mg |
EUR 825 |
Recombinant Human IL2 |
|
MBS4159676-5x1mg |
MyBiosource |
5x1mg |
EUR 3470 |
Recombinant Human IL3 |
|
MBS4159679-001mg |
MyBiosource |
0.01mg |
EUR 230 |
Recombinant Human IL3 |
|
MBS4159679-005mg |
MyBiosource |
0.05mg |
EUR 300 |
Recombinant Human IL3 |
|
MBS4159679-1mg |
MyBiosource |
1mg |
EUR 2710 |
Recombinant Human IL3 |
|
MBS4159679-5x1mg |
MyBiosource |
5x1mg |
EUR 11950 |
Recombinant Human IL4 |
|
MBS4159682-001mg |
MyBiosource |
0.01mg |
EUR 205 |
Recombinant Human IL4 |
|
MBS4159682-01mg |
MyBiosource |
0.1mg |
EUR 660 |
Recombinant Human IL4 |
|
MBS4159682-1mg |
MyBiosource |
1mg |
EUR 4080 |
Recombinant Human IL4 |
|
MBS4159682-5x1mg |
MyBiosource |
5x1mg |
EUR 18115 |
Recombinant Human IL6 |
|
MBS4159683-002mg |
MyBiosource |
0.02mg |
EUR 385 |
Recombinant Human IL6 |
|
MBS4159683-01mg |
MyBiosource |
0.1mg |
EUR 1220 |
Recombinant Human IL6 |
|
MBS4159683-10x01mg |
MyBiosource |
10x0.1mg |
EUR 4960 |
Recombinant Human LIF |
|
MBS4159687-001mg |
MyBiosource |
0.01mg |
EUR 230 |
Recombinant Human LIF |
|
MBS4159687-01mg |
MyBiosource |
0.1mg |
EUR 535 |
Recombinant Human LIF |
|
MBS4159687-1mg |
MyBiosource |
1mg |
EUR 1845 |
Recombinant Human LIF |
|
MBS4159687-5x1mg |
MyBiosource |
5x1mg |
EUR 8070 |
Recombinant Human OSM |
|
MBS4159701-001mg |
MyBiosource |
0.01mg |
EUR 230 |
Recombinant Human OSM |
|
MBS4159701-02mg |
MyBiosource |
0.2mg |
EUR 1180 |
Recombinant Human OSM |
|
MBS4159701-1mg |
MyBiosource |
1mg |
EUR 2445 |
Recombinant Human OSM |
|
MBS4159701-5x1mg |
MyBiosource |
5x1mg |
EUR 10755 |
Recombinant Human PTH |
|
MBS4159703-01mg |
MyBiosource |
0.1mg |
EUR 230 |
Recombinant Human PTH |
|
MBS4159703-1mg |
MyBiosource |
1(mg) |
EUR 930 |
Recombinant Human PTH |
|
MBS4159703-2mg |
MyBiosource |
2mg |
EUR 1430 |
Recombinant Human PTH |
|
MBS4159703-5x2mg |
MyBiosource |
5x2mg |
EUR 6190 |
Recombinant Human SCF |
|
MBS4159707-001mg |
MyBiosource |
0.01mg |
EUR 260 |
Recombinant Human SCF |
|
MBS4159707-01mg |
MyBiosource |
0.1mg |
EUR 670 |
Recombinant Human SCF |
|
MBS4159707-10x01mg |
MyBiosource |
10x0.1mg |
EUR 2815 |
Recombinant Human TNF |
|
MBS4159709-005mg |
MyBiosource |
0.05mg |
EUR 230 |
Recombinant Human TNF |
|
MBS4159709-01mg |
MyBiosource |
0.1mg |
EUR 285 |
Recombinant Human TNF |
|
MBS4159709-1mg |
MyBiosource |
1mg |
EUR 845 |
Recombinant Human TNF |
|
MBS4159709-5x1mg |
MyBiosource |
5x1mg |
EUR 3550 |
Recombinant Human LTA |
|
MBS4159710-002mg |
MyBiosource |
0.02mg |
EUR 230 |
Recombinant Human LTA |
|
MBS4159710-01mg |
MyBiosource |
0.1mg |
EUR 515 |
Recombinant Human LTA |
|
MBS4159710-1mg |
MyBiosource |
1mg |
EUR 1845 |
Recombinant Human LTA |
|
MBS4159710-5x1mg |
MyBiosource |
5x1mg |
EUR 8070 |
Recombinant Human MIF |
|
MBS4159713-0025mg |
MyBiosource |
0.025mg |
EUR 225 |
Recombinant Human MIF |
|
MBS4159713-01mg |
MyBiosource |
0.1mg |
EUR 410 |
Recombinant Human MIF |
|
MBS4159713-1mg |
MyBiosource |
1mg |
EUR 1440 |
Recombinant Human MIF |
|
MBS4159713-5x1mg |
MyBiosource |
5x1mg |
EUR 6240 |
Recombinant Human IL7 |
|
MBS4159719-001mg |
MyBiosource |
0.01mg |
EUR 230 |
Recombinant Human IL7 |
|
MBS4159719-01mg |
MyBiosource |
0.1mg |
EUR 660 |
Recombinant Human IL7 |
|
MBS4159719-1mg |
MyBiosource |
1mg |
EUR 7935 |
Recombinant Human EPO |
|
MBS4159762-005mg |
MyBiosource |
0.05mg |
EUR 225 |
Recombinant Human EPO |
|
MBS4159762-05mg |
MyBiosource |
0.5mg |
EUR 535 |
In short, these findings indicate that leptin may be the main molecule that mediates the effects of adipocytes in inflammatory cells such as basophiles by binding LEPR and activating cellular functions, which may worsen allergic inflammation.